25th May 2022 | New start-up
New start-up company RecTech GmbH has been founded.
SaxoCell will establish a lighthouse for cell and gene therapies in Saxony, featuring high international visibility. Here you will find a selection of news and information about our cluster. We are looking forward to press and media inquiries, please contact us.
17th May 2022 | Annual Report 2021
SaxoCell Annual Report 2021 has been published.
28th April 2022 | Popular science lecture
New Perspectives of Cell Therapy
Prof. Dr. Martin Bornhäuser, University Hospital Carl Gustav Carus
21st January 2022 | Press release
Designer recombinase can precisely correct disease-relevant gene defect in severe form of hemophilia A
18th November 2021 | Press release
SaxoCell explores therapies for as-yet incurable diseases
3rd February 2021 | Press release
Living medicines: The SaxoCell innovation network is one of the winners of the first BMBF future cluster round
4th May 2020 | Press release
Starting shot for the concept phase: From excellent science to application – the innovation project SaxoCell in the BMBF competition “Clusters4Future”
28th February 2020 | Press release
SaxoCell innovation project in the final of the “Clusters4Future” competition: With “living drugs” against cancer and other common diseases
5th February 2020 | Press release
These are the finalists in the competition for the innovation networks of the future: Clusters4Future: Jury recommends 16 applications for funding.
Dr. Maren Henneken
Center for Regenerative Therapies Dresden (CRTD), Technical University of Dresden
Medical Clinic I, Hematology, Cell Therapy and Hemostaseology, University of Leipzig
Dr. Annette Bartsch
Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig
Dr. Stefanie Binder
Institute for Clinical Immunology, University of Leipzig